← All companies

PGEN

Precigen, Inc.

PGEN Nasdaq Pharmaceutical Preparations EDGAR ↗

$6.61

+0.67 +11.28%

Key statistics

from XBRL data in SEC filings

Market cap

$2.36B

Revenue (TTM)

$9.68M

Net income (TTM)

-$204M

EPS (TTM)

$-1.21

P/E ratio

—

Dividend yield

—

Free cash flow

-$89.8M

Cash

$7.48M

Total assets

$139M

Gross margin

—

52-week range

$1.70 – $6.70

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Shareholder vote results Jun 24, 2026 8-K Results of operations (earnings release) May 13, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Results of operations (earnings release) Mar 25, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Unregistered sale of equity Sep 17, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Sep 3, 2025 8-K Entered a material agreement Aug 18, 2025 8-K Regulation FD disclosure Aug 18, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Director or officer change; Shareholder vote results Jun 30, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 19, 2025 8-K Results of operations (earnings release) Mar 19, 2025 8-K Other events Jan 16, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure; Other events Dec 30, 2024 8-K Entered a material agreement Dec 26, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Delisting notice or listing-rule failure Nov 7, 2024 8-K Terminated a material agreement Oct 10, 2024 8-K Director or officer change Sep 23, 2024 8-K Director or officer change Aug 30, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release) Aug 14, 2024 8-K Entered a material agreement Aug 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Aug 6, 2024 8-K Director or officer change; Shareholder vote results Jul 5, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 29, 2024 10-K Fiscal year ended 2023-12-31 Mar 19, 2024 8-K Results of operations (earnings release) Mar 19, 2024 8-K Director or officer change Feb 8, 2024 8-K Regulation FD disclosure Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023